Clinical Scorecard: Case Study: Early T-cell Precursor Acute Lymphoblastic Leukemia Arising from Donor Cells After Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Severe Aplastic Anemia

At a Glance

Key Highlights

• Donor cell leukemia (DCL) is a rare complication post-allo-HSCT.
• The patient developed ETP-ALL 2 years and 5 months after transplantation.
• Multiple chemotherapy regimens were administered without achieving remission.
• The case highlights the refractory nature of donor cell leukemia.
• Investigation into molecular mechanisms is needed for better prevention strategies.

Guideline-Based Recommendations

Diagnosis

• Utilize short tandem repeat (STR) chimerism analysis for accurate detection of donor-derived cells.

Management

• Administer appropriate chemotherapy regimens for acute lymphoblastic leukemia.

Monitoring & Follow-up

• Routine monitoring of peripheral blood chimerism post-transplantation.

Risks

• Inherent tumor precursor characteristics of umbilical cord blood cells.

Patient & Prescribing Data

Child with severe aplastic anemia undergoing allo-HSCT.

The patient received cyclosporine, mycophenolate mofetil, and methotrexate for GVHD prophylaxis.

Clinical Best Practices

• Ensure informed consent is obtained prior to transplantation and diagnostic testing.
• Monitor for complications such as gastrointestinal GVHD and infections post-transplant.

Related Resources & Content

• Guidelines for the Diagnosis and Treatment of Pediatric Aplastic Anemia